Sodium Nitroprusside Injection
Product Images NDC 55150-320

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sodium Nitroprusside (NDC 55150-320). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Auromedics Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Metabolism Of Sodium Nitroprusside (Sodiumnitro Fig1)

A metabolic pathway diagram illustrating the metabolism of sodium nitroprusside. It shows interactions between nitroprusside, hemoglobin (Hgb), cyanide, thiocyanate, methemoglobin (metHgb), and thiosulfate, with enzymatic steps involving rhodanase and renal excretion pathways. The diagram highlights active and inactive cytochromes and the conversion processes among these compounds.*

FDA Label Image

Package Label-principal Display Panel (50 mg/2 mL (25 mg/mL))

Sodium Nitroprusside Injection 50 mg/2 mL (25 mg/mL) single-dose vial label by AuroMedics Pharma LLC. The label includes instructions to protect from light and to monitor blood pressure before and during administration. It states the product is for intravenous infusion only and is manufactured in India for AuroMedics Pharma LLC, East Windsor, NJ.*

FDA Label Image

Package Label-principal Display Panel (50 mg/2 mL (25 mg/mL))

Packaging label for Sodium Nitroprusside Injection 50 mg/2 mL (25 mg/mL) by AuroMedics Pharma LLC. The label states it is for intravenous infusion only, must be diluted, and includes dosing and storage instructions. The label also notes that the vial stopper is not made with natural rubber latex and provides distributor address information.*

FDA Label Image

Package Label-principal Display Panel (50 mg per 2 mL (25 mg / mL) – Light Protective Sleeve)

A dosing and handling instruction panel for Sodium Nitroprusside (Infusion) injection. It includes fields for concentration and dilution details in 5% Dextrose Injection, USP, with spaces to record dilution and expiration dates and times. The text emphasizes protection from light, discarding the solution 24 hours after dilution, and restricting addition of other medications. Distributor information for AuroMedics Pharma LLC and manufacturing origin in India are also shown.*

FDA Label Image

Package Label-principal Display Panel (Carton of Light Protective Sleeve)

Label for Sodium Nitroprusside injection (infusion) from AuroMedics Pharma LLC. The label emphasizes the inclusion of a light protective sleeve to shield the infusion solution from light. It includes the manufacturer's address in E. Windsor, NJ, and the AUROMEDICS logo. No specific strength or dosage form details are visible beyond indicating it is an infusion.*

FDA Label Image

Chemical Structure (Sodiumnitro Str)

Chemical structure of Sodium Nitroprusside, showing an iron (Fe) center coordinated by five cyanide (CN) groups and one nitrosyl (ON) group, with two sodium (Na+) ions and two water molecules (2 H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.